These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37247084)

  • 1. Characterization and synergy studies of Caudoviricete Escherichia phage FS2B infecting multi-drug resistant uropathogenic Escherichia coli isolates.
    Malik S; Nehra K; Mann A; Jagdish R; Rana JS
    Int Microbiol; 2024 Feb; 27(1):155-166. PubMed ID: 37247084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and Characterization of Novel Lytic Phages Infecting Multidrug-Resistant Escherichia coli.
    Vera-Mansilla J; Sánchez P; Silva-Valenzuela CA; Molina-Quiroz RC
    Microbiol Spectr; 2022 Feb; 10(1):e0167821. PubMed ID: 35171030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage cocktail and phage antibiotic synergism as promising alternatives to conventional antibiotics for the control of multi-drug-resistant uropathogenic Escherichia coli.
    Malik S; Nehra K; Rana JS
    Virus Res; 2021 Sep; 302():198496. PubMed ID: 34182014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India.
    Chaudhary N; Mohan B; Mavuduru RS; Kumar Y; Taneja N
    J Appl Microbiol; 2022 Apr; 132(4):3387-3404. PubMed ID: 34989075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
    Zulk JJ; Clark JR; Ottinger S; Ballard MB; Mejia ME; Mercado-Evans V; Heckmann ER; Sanchez BC; Trautner BW; Maresso AW; Patras KA
    mSphere; 2022 Aug; 7(4):e0034522. PubMed ID: 35920561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of bacteriophages infecting multidrug-resistant uropathogenic Escherichia coli strains.
    Markusková B; Elnwrani S; Andrezál M; Sedláčková T; Szemes T; Slobodníková L; Kajsik M; Drahovská H
    Arch Virol; 2024 Jun; 169(7):142. PubMed ID: 38851653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of bacteriophages against E.coli urinary tract infection and evaluating their anti-biofilm activity and antibiotic synergy.
    Devi B A; K V L; Sugumar S
    Microb Pathog; 2024 Aug; 193():106789. PubMed ID: 38972365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of class 1 integrons and plasmid profile among multiple drug resistant uropathogenic Escherichia coli.
    Javed S; Mirani ZA; Pirzada ZA
    Pak J Pharm Sci; 2020 Nov; 33(6):2643-2649. PubMed ID: 33867342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and characterisation of new phage targeting uropathogenic Escherichia coli.
    Asgharzadeh Kangachar S; Logel DY; Trofimova E; Zhu HX; Zaugg J; Schembri MA; Weynberg KD; Jaschke PR
    Virology; 2024 Sep; 597():110148. PubMed ID: 38941748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.
    González-Villalobos E; Ribas-Aparicio RM; Montealegre GER; Belmont-Monroy L; Ortega-García Y; Aparicio-Ozores G; Balcázar JL; Eslava-Campos CA; Hernández-Chiñas U; Molina-López J
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5617-5629. PubMed ID: 34254156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage vB_Ec_ZCEC14 to treat antibiotic-resistant Escherichia coli isolated from urinary tract infections.
    Ismael NM; Azzam M; Abdelmoteleb M; El-Shibiny A
    Virol J; 2024 Feb; 21(1):44. PubMed ID: 38365702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Discovery of Genes Required for Capsule Production by Uropathogenic
    Goh KGK; Phan MD; Forde BM; Chong TM; Yin WF; Chan KG; Ulett GC; Sweet MJ; Beatson SA; Schembri MA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome Analysis and Antibiofilm Activity of Phage 590B against Multidrug-Resistant and Extensively Drug-Resistant Uropathogenic
    Chaudhary N; Maurya RK; Singh D; Mohan B; Taneja N
    Pathogens; 2022 Nov; 11(12):. PubMed ID: 36558782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Anti-Bacterial Effect of the Two New Phages against Uropathogenic
    Slobodníková L; Markusková B; Kajsík M; Andrezál M; Straka M; Liptáková A; Drahovská H
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic epidemiology and antibiotic susceptibility profiling of uropathogenic
    Salamzade R; McElheny CL; Manson AL; Earl AM; Shaikh N; Doi Y
    mSphere; 2023 Oct; 8(5):e0018423. PubMed ID: 37581436
    [No Abstract]   [Full Text] [Related]  

  • 16. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
    Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
    Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Previous Antibiotic Exposure Reshapes the Population Structure of Infecting Uropathogenic Escherichia coli Strains by Selecting for Antibiotic Resistance over Urovirulence.
    Ballash GA; Diaz-Campos D; van Balen JC; Mollenkopf DF; Wittum TE
    Microbiol Spectr; 2023 Aug; 11(4):e0524222. PubMed ID: 37338386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and in vitro activity of a lytic phage RDN37 isolated from community sewage water active against MDR Uropathogenic E. coli.
    Chaudhary N; Narayan C; Mohan B; Taneja N
    Indian J Med Microbiol; 2021 Jul; 39(3):343-348. PubMed ID: 33994226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of antibiotic resistance determinants and virulence factors of uropathogenic Escherichia coli.
    Sun DH; Lv DF; Mi ZH; Hu LQ; Huang Y; Gao X; Weng XB
    J Antibiot (Tokyo); 2020 May; 73(5):314-319. PubMed ID: 32076117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic characterization of two bacteriophages (vB_EcoS-phiEc3 and vB_EcoS-phiEc4) belonging to the genus Kagunavirus with lytic activity against uropathogenic Escherichia coli.
    Rodea GE; González-Villalobos E; Medina-Contreras O; Castelán-Sánchez HG; Aguilar-Rodea P; Velázquez-Guadarrama N; Hernández-Chiñas U; Eslava-Campos CA; Balcázar JL; Molina-López J
    Microb Pathog; 2022 Apr; 165():105494. PubMed ID: 35314281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.